On July 28, Elevance Health declined 4.02% in regular trading, trading at $370.755/share with turnover of $91.43 million. The managed healthcare sector faced widespread selling pressure, with Centene falling 9.06%, Molina Healthcare declining 6.16%, Humana dropping 2.51%, and Progyny losing 3.89%.

The sector-wide weakness reflects ongoing concerns about Medicaid utilization pressure. During its recent Q2 earnings call, Elevance Health's CEO indicated the company expects to exit more Medicaid markets over the next 12 to 18 months due to challenging operating conditions. RBC Capital Markets noted that Medicaid utilization pressure among the continuing member base and planned market exits are cooling expectations around Medicaid recovery momentum. Despite beating Q2 earnings expectations with adjusted EPS of $7.45 versus estimates of $6.21 and raising full-year adjusted EPS guidance to at least $27.00, operating margin compression from 4.9% to 3.5% year-over-year continues to weigh on sentiment across managed care names.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)